Algert Global’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Algert Global’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-28,520	Closed	-$2.51M	–	543
2019 Q4	$2.51M	Buy	28,520 +7,644	+37%	+$645K	0.75%	24
2019 Q3	$1.57M	Buy	20,876 +9,988	+92%	+$811K	0.59%	56
2019 Q2	$930K	Buy	10,888 +6,817	+167%	+$674K	0.34%	104
2019 Q1	$440K	Buy	+4,071	New	+$405K	0.25%	141

Other funds holding TARO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Algert Global's TARO Position: Q1 2020 in Review

Algert Global sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2020, closing a stake of 28,520 shares — an estimated $2.51M sold.

Algert Global first reported a position in TARO in Q1 2019 and held it in 4 quarters. The position peaked at $2.51M in Q4 2019. 90 funds tracked by Wall St. Rank hold TARO as of Q1 2020.

Algert Global reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2020 after selling out during the quarter.
Algert Global sold 28,520 Taro Pharmaceutical Industries Ltd. shares in Q1 2020, an estimated $2.51M.
Algert Global first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2019 and held it in 4 quarters.
Algert Global's Taro Pharmaceutical Industries Ltd. position peaked at $2.51M in Q4 2019.
90 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2020.

Based on Algert Global's 13F filing for Q1 2020, filed 13 May 2020.